Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients

Background. The outbreak of Coronavirus Disease 2019 (COVID-19) has been increasing rapidly. This disease causes an increase in proinflammatory cytokine production that leads to cytokine storm or cytokine release syndrome (CRS). Autologous activated platelet-rich plasma (aaPRP) contains various type...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Karina Karina, Iis Rosliana, Imam Rosadi, Siti Sobariah, Louis Martin Christoffel, Rita Novariani, Siti Rosidah, Novy Fatkhurohman, Yuli Hertati, Nurlaela Puspitaningrum, Wismo Reja Subroto, Irsyah Afini, Difky Ernanda
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2021-01-01
coleção:	International Journal of Inflammation
Acesso em linha:	http://dx.doi.org/10.1155/2021/5531873
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!